@MarcJacksonLA stock setter
Several companies across various sectors have recent target changes from analysts. Notable changes include upgrades and downgrades for companies such as American Tower, EOG Resources, and Aptiv. Additionally, some companies like Alaska Airlines and UnitedHealth have made significant announcements that may impact their stock performance. Analysts are also showing interest in companies like Neurocrine Biosciences and Faraday Future.
Engagements: [-----] #
- [--] Week [-------] -1.80%
- [--] Month [-------] +57%
- [--] Months [---------] -17%
- [--] Year [---------] +20%
Mentions: [---] #
- [--] Week [-----] -3.40%
- [--] Month [-----] +2.70%
- [--] Months [------] +1.80%
- [--] Year [------] +28%
Followers: [-----] #
- [--] Week [-----] +0.25%
- [--] Month [-----] +0.90%
- [--] Months [-----] +6.20%
- [--] Year [-----] +27%
CreatorRank: [-------] #
Social Influence
Social category influence stocks 86.15% cryptocurrencies 30.93% technology brands 13.22% financial services #1024 finance 6.79% countries 5.38% currencies 2.51% automotive brands 2.3% exchanges 1.1% fashion brands 0.57%
Social topic influence target #870, $barcl #41, morgan stanley #27, rating #1044, bank of #392, bank of america #66, bank #1246, hold #284, health 2.66%, $19 #62
Top accounts mentioned or mentioned by @statnews @medtechdive @biopharmadive @teamimugene @trialsarena @fwpharma @barchart @ophthalmology @genetherapylive @mitchellreed09 @pharmatechfocus @ft @businessinsider @streetinsider @bitcoinmagazine @bs @biopharmajournal @americanbanking @thedalesreport @wdrbnews
Top assets mentioned Morgan Stanley (MS) Bank of America (BAC) Born in [--] (19) 2131KOBUSHIDE (21) The Official [--] Coin (93) The Official [--] coin (76) HSBC Holdings PLC (HSBC) Flutter Entertainment plc (FLUT) Johnson & Johnson (JNJ) The 99% Community (99) 69Coin (69) AstraZeneca PLC (AZN) Gilead Sciences, Inc. (GILD) Merck & Co., Inc. (MRK) Novartis AG (NVS) Atlassian Corporation PLC (TEAM) The Official [--] Coin (89) (89) Amgen, Inc. (AMGN) GSK plc (GSK) Evolent Health, Inc Class A Common Stock (EVH) Pinterest, Inc. (PINS) monday.com Ltd. (MNDY) PayPal Holdings Inc (PYPL) Hims & Hers Health, Inc. (HIMS) Inspect (INSP) DuPont de Nemours Inc (DD) Basilisk (BSX) Now Coin (NOW) CatCoin (CAT) Walmart, Inc. (WMT) Doximity, Inc. (DOCS) Legend Biotech Corp (LEGN) Novo-Nordisk (NVO) Baker Hughes Co (BKR) Pfizer, Inc. (PFE) Rapids (RPD) Intuit Inc. (INTU) Datadog Inc (DDOG) FedEx Corporation (FDX) Workday Inc (WDAY) Hilton Hotels Corporation Common Stock (HLT) Waystar Holding Corp (WAY) Teradyne, Inc. (TER) Erasca, Inc. (ERAS) HUBSPOT, INC. (HUBS) Regal Rexnord, Corp. (RRX) Klarna Group plc (KLAR) Coca-Cola Co (KO) Cisco Systems Inc (CSCO) Synthetify (SNY) Mario Coin (COIN) AME Chain (AME) Evommune, Inc. (EVMN) Hasbro, Inc. (HAS) Adobe, Inc. (ADBE) Adappter Token (ADP) Marriott International Inc (MAR) Western Digital Corp (WDC) MKS Instruments Inc (MKSI) Paylocity Holding, Corp. (PCTY) GUIDEWIRE SOFTWARE, INC. (GWRE) Paycom Software Inc (PAYC) Zillow Group, Inc. (ZG) Analog Devices, Inc. (ADI) Bristol-Myers Squibb Co (BMY) Applied Materials, Inc. (AMAT) Emerson Electric Co. (EMR) StaFi (FIS) Salesforce Inc (CRM) Powell Industries Inc (POWL) Gemini Space Station, Inc. (GEMI) IPG Photonics Corporation (IPGP) Kyndryl Holdings, Inc. (KD)
Top Social Posts
Top posts by engagements in the last [--] hours
"$BBIO $BMRN $ASND $SNY BridgeBio preps approval push after dwarfism drug increases children's height in phase [--] https://www.fiercebiotech.com/biotech/bridgebio-preps-approval-push-after-dwarfism-drug-increases-height-children-phase-3 https://www.fiercebiotech.com/biotech/bridgebio-preps-approval-push-after-dwarfism-drug-increases-height-children-phase-3"
X Link 2026-02-12T16:10Z [----] followers, [---] engagements
"$JACK -Citi raises Jack in the Box target to $23 from $16 Neutral - $JCI -JPMorgan raises Johnson Controls target to $158 from $138 Overweight - $JMIA -Cantor Fitzgerald initiates Jumia coverage at Overweight $18 target https://www.investing.com/news/analyst-ratings/cantor-fitzgerald-initiates-jumia-technologies-stock-coverage-with-overweight-rating-93CH-4489669 https://www.investing.com/news/analyst-ratings/cantor-fitzgerald-initiates-jumia-technologies-stock-coverage-with-overweight-rating-93CH-4489669"
X Link 2026-02-07T23:04Z [----] followers, [---] engagements
"$FSLY -Citi raises Fastly target to $13 from $10 Neutral - $FTS -RBC Scotiabank raises Fortis target to C$80 from C$79 Sector Perform -BMO raises target to C$77 from C$74 Market Perform -"
X Link 2026-02-14T20:31Z [----] followers, [---] engagements
"$IPGP -Raymond James raises IPG Photonics target to $180 from $97 Downgrades to Outperform from Strong Buy -Stifel raises target to $165 from $92 Buy - $ITRI -Guggenheim downgrades Itron to Neutral from Buy $155 target - $KD -Susquehanna lowers Kyndryl target to $16 from $35 Positive - https://twitter.com/i/web/status/2023089582217347500 https://twitter.com/i/web/status/2023089582217347500"
X Link 2026-02-15T17:38Z [----] followers, [---] engagements
"$CC -RBC raises Chemours target to $18 from $16 Outperform $CCEP -Barclays lifts Coca-Cola Europacific Partners target to $101 from $99 Overweight $CCI -Goldman lowers Crown Castle target to $103 from $120 Neutral $CE -RBC raises Celanese target to $48 from $43 Sector Perform"
X Link 2026-01-16T20:50Z [----] followers, [---] engagements
"$MDGL Madrigal pens $4.4B deal for Ribo's preclinical siRNA programs in latest Rezdiffra MASH play https://www.fiercebiotech.com/biotech/madrigal-pens-44b-deal-ribos-sirna-programs-latest-rezdiffra-mash-play https://www.fiercebiotech.com/biotech/madrigal-pens-44b-deal-ribos-sirna-programs-latest-rezdiffra-mash-play"
X Link 2026-02-11T15:59Z [----] followers, [---] engagements
"Notable [--] Week Highs Cont. from Part [--] $PSX $PWR $Q $QXO $RAIL $RBC $RF $RIG $RIO $RLAY $RMCF $RNR $ROAD $ROG $ROST $RS $RUSHA $RWT $SB $SBLK $SBS $SCL $SDRL $SGI $SHG $SHIP $SIF $SIMO $SITE $SITM $SKM $SLB $SLF $SMFG $SN Part [--] Cont. -"
X Link 2026-02-12T17:27Z [----] followers, [---] engagements
"$ONC $GILD $RHHBY $DSNKY $MKKGY NK-cell engagers see another discontinuation https://www.oncologypipeline.com/apexonco/nk-cell-engagers-see-another-discontinuation https://www.oncologypipeline.com/apexonco/nk-cell-engagers-see-another-discontinuation"
X Link 2026-02-13T16:43Z [----] followers, [---] engagements
"$COR -Barclays raises Cencora target to$425 from $400 Overweight - $CPA -Barclays raises Copa target to $185 from $150 Overweight -Evercore raises target to $185 from $160 Overweight - $CRK -Morgan Stanley lowers Comstock Resources to $19 from $20 = Weight -UBS lowers target to $17 from $18 Sell - https://twitter.com/i/web/status/2022463036808925676 https://twitter.com/i/web/status/2022463036808925676"
X Link 2026-02-14T00:08Z [----] followers, [---] engagements
"$INTS Intensity Therapeutics Announces 1-for-25 Reverse Stock Split - Intensity's common stock is expected to begin trading on a post-split adjusted basis on February [--] [----] https://www.stocktitan.net/news/INTS/intensity-therapeutics-announces-reverse-stock-hvr0x1txphqo.html https://www.stocktitan.net/news/INTS/intensity-therapeutics-announces-reverse-stock-hvr0x1txphqo.html"
X Link 2026-02-15T07:40Z [----] followers, [---] engagements
"$MT -Citi raises ArcelorMittal target to [--] from [--] Buy - $MTRN -KeyBanc raises Materion target to $170 from $159 Overweight - $NBIX -Wells Fargo lowers Neurocrine Biosciences target to $175 from $180 Overweight -"
X Link 2026-02-15T17:50Z [----] followers, [--] engagements
"$CGTX -B. Riley raises Cognition Therapeutics target to $3 from $2 Buy - $CNC -Bernstein lifts Centene target to $45 from $36 Outperform - $CNX -Scotiabank raises CNX Resources target to $40 from $36 Sector Perform _ $COIN -Goldman lowers Coinbase target to $314 from $368 Neutral"
X Link 2025-11-22T21:48Z [----] followers, [---] engagements
"$CBRE -Barclays initiates CBRE Group coverage at Overweight $190 target - $CBRL -UBS lowers Cracker Barrel target to $30 from $48 Neutral - $CCCC -Cowen initiates C4 Therapeutics coverage at Buy likes firm's protein degradation technology https://m.investing.com/news/analyst-ratings/c4-therapeutics-stock-initiated-with-buy-rating-at-td-cowen-93CH-4385544ampMode=1 https://m.investing.com/news/analyst-ratings/c4-therapeutics-stock-initiated-with-buy-rating-at-td-cowen-93CH-4385544ampMode=1"
X Link 2025-12-02T15:54Z [----] followers, [---] engagements
"$COTY -Barclays lowers Coty target to $3 from $3.50 Underweight - $CPB -Morgan Stanley lowers Campbell's target to $28 from $30 = Weight -Barclays lowers target to $27 from $30 = Weight - $CPNG -Deutsche Bank upgrades Coupang to Buy from Hold Lowers target to $25 from $29 -"
X Link 2026-01-18T01:08Z [----] followers, [---] engagements
"Notable [--] Week Highs $ABCB $ACGL $ACT $AGCO $AIR $ALGM $ALM $ALNT $ALRS $AMAL $AME $AMGN $AOS $AP $ARCB $ARCO $AROC $ARW $ASB $ASO $AUB $AVBH $AVT $AVY $BALL $BBT $BBVA $BCE $BFC $BFST $BG $BHE $BKH $BKR $BLFY $BMO $BNL $BORR $BP $BPOP $BTI $BUD $BUSE $BW $BWA Part [--] Cont. -"
X Link 2026-02-04T15:52Z [----] followers, [---] engagements
"$AFRM -Mizuho lowers Affirm target to $95 from $114 Outperform -Cantor Fitzgerald maintains $85 target Overweight - $AGCO -Truist raises AGCO target to $152 from $134 Buy -Wells Fargo raises target to $132 from $114 = Weight -Citi raises target to $130 from $120 Neutral -"
X Link 2026-02-09T18:18Z [----] followers, [---] engagements
"$BMRN $FOLD $BBIO $ASND $TYRA BioMarin Bet on Amicus To Ease Voxzogos Decline. Will It Work https://www.biospace.com/business/biomarin-bet-on-amicus-to-ease-voxzogos-decline-will-it-work https://www.biospace.com/business/biomarin-bet-on-amicus-to-ease-voxzogos-decline-will-it-work"
X Link 2026-02-12T15:52Z [----] followers, [---] engagements
"$PTON -Citi lowers Peloton target to $5 from $8.25 Neutral - $QTWO -Cantor Fitzgerald lowers Q2 target to $80 from $90 Overweight -Truist lowers target to $75 from $110 Buy -Stifel lowers target to $75 from $90 Buy -Morgan Stanley lowers target to $68 from $82 = Weight -RBC lowers target to $67 from $86 Sector Perform - https://twitter.com/i/web/status/2022118669120340085 https://twitter.com/i/web/status/2022118669120340085"
X Link 2026-02-13T01:20Z [----] followers, [---] engagements
"$CHKP -Cowen lowers Check Point Software to $260 from $285 Buy -Baird lowers target to $220from $245 Outperform -BMO Wedbush lower target to $210 from $240 Outperform -Stephens lowers target to $210from $240 Overweight -Mizuho lowers target to $205 from $225 Neutral -Barclays lowers target to $195 from $220 = Weight -Evercore lowers target to $185 from $208 In-Line -Deutsche Bank lowers target to $180 from $200 Hold -Scotiabank lowers target to $180 from $195 Sector Perform - https://twitter.com/i/web/status/2022406592344527225 https://twitter.com/i/web/status/2022406592344527225"
X Link 2026-02-13T20:24Z [----] followers, [---] engagements
"$PTCT Final US chapter for PTC's DMD therapy Translarna as FDA bar proves too high via @fwpharma https://firstwordpharma.com/story/7103468 https://firstwordpharma.com/story/7103468"
X Link 2026-02-13T20:39Z [----] followers, [---] engagements
"$DNA Ginkgo Bioworks' Autonomous Laboratory Driven by OpenAI's GPT-5 Achieves 40% Improvement Over State-of-the-Art Scientific Benchmark https://www.prnewswire.com/news-releases/ginkgo-bioworks-autonomous-laboratory-driven-by-openais-gpt-5-achieves-40-improvement-over-state-of-the-art-scientific-benchmark-302680619.html https://www.prnewswire.com/news-releases/ginkgo-bioworks-autonomous-laboratory-driven-by-openais-gpt-5-achieves-40-improvement-over-state-of-the-art-scientific-benchmark-302680619.html"
X Link 2026-02-15T03:51Z [----] followers, [---] engagements
"$SPXC -Bank of America upgrades SPX Technologies to Buy from Neutral Raises target to $280 from $240 - $STNG -B. Riley raises Scorpio Tankers target to $90 from $80 Buy -Deutsche Bank raises target to $83 from $76 Buy -Evercore lowers target to $83 from $86 Outperform -"
X Link 2026-02-15T20:59Z [----] followers, [---] engagements
"$TCRX -Needham lowers Tscan Therapeutics target to $6 from $9 Buy -BTIG downgrades to Neutral from Buy - $TEL -Barclays raises TE Connectivity target to $277 from $249 Overweight - $TERN -Barclays raises Terns Pharmaceuticals target to $28 from $20 Buy -Barclays to $27 from $14 Overweight https://twitter.com/i/web/status/1985912387455594687 https://twitter.com/i/web/status/1985912387455594687"
X Link 2025-11-05T03:29Z [----] followers, [---] engagements
"$TEAM -Bernstein raises Atlassian target to $304 from $290 Outperform - $TELA -Canaccord lowers TELA Bio target to $4 from $7 Buy - $TERN -BMO raises Terns Pharmaceuticals target to $30 from $22 Outperform - $TKO -BTIG reiterates TKO Group $235 target Buy -"
X Link 2025-11-19T02:27Z [----] followers, [---] engagements
"$WSO -KeyBanc maintains Watsco Sector Weight rating - $WTS -Jefferies initiates Watts Water Technologies coverage at Hold $300 target - $WTW -Keefe Bruyette & Woods raises Willis Towers Watson target to $375 from $373 Outperform -Wells Fargo lowers target to$356 from$362 Overweight - https://twitter.com/i/web/status/2000254464796840268 https://twitter.com/i/web/status/2000254464796840268"
X Link 2025-12-14T17:20Z [----] followers, [---] engagements
"$LFS LEIFRAS Reports Financial Results for the Nine Months Ended September [--] [----] LEIFRAS reported revenue JPY8.6B (+15.3% YoY) gross profit JPY2.4B (+18.1% YoY) and gross margin 28.2% (vs 27.5%). Net income was JPY226.7M (+0.7% YoY) and basic/diluted EPS was JPY9.10. Operationally sports school members rose to [-----] (+2.3%) and schools served in social business increased to [---] (+53.2%). Cash was JPY2.4B as of Sept [--] [----]. The company projected full-year [----] revenue of JPY11.611.9B (+11.9%15.3%) and operating income of JPY580.0696.5M."
X Link 2025-12-18T21:05Z [----] followers, [---] engagements
"$MDLN -Analysts initiate Medline coverage after IPO flag growth visibility and margin https://www.investing.com/news/stock-market-news/analysts-initiate-coverage-on-medline-after-ipo-flag-growth-visibility-and-margin-4442854 https://www.investing.com/news/stock-market-news/analysts-initiate-coverage-on-medline-after-ipo-flag-growth-visibility-and-margin-4442854"
X Link 2026-01-13T01:37Z [----] followers, [---] engagements
"$GOOGL -Goldman raises Alphabet target to $375 from $330 Buy -Bank of America lifts target to $370 from $335 Buy - $H -Miz uho raises Hyatt Hotels target to $223 from $203 outperform - $HIG -Wells Fargo raises Hartford Insurance target to $153 from $140 Overweight -"
X Link 2026-01-14T00:59Z [----] followers, [---] engagements
"$SRCE -DA Davidson raises 1st Source target to $74 from $69 Buy - $SRPT -Barclays assumes Sarepta Therapeutics coverage at = Weight $20 target - $STAA -Jefferies lowers STAAR Surgical target to $21.50 from $28 Buy -"
X Link 2026-01-29T02:04Z [----] followers, [---] engagements
"$QCOM -Bernstein lowers Qualcomm target to $200 from $215 Outperform -Cantor Fitzgerald lowers target to $160 from $185 Neutral - $RAPP -Wells Fargo initiates Rapport Therapeutics with an Overweight rating $43 target -"
X Link 2026-02-03T01:07Z [----] followers, [---] engagements
"$SRPT Sarepta Therapeutics Announces Approval of Clinical Trial Application for SRP-1005 Its Investigational Treatment for Huntingtons Disease https://www.stocktitan.net/news/SRPT/sarepta-therapeutics-announces-approval-of-clinical-trial-4xpj1gt0hg5d.html https://www.stocktitan.net/news/SRPT/sarepta-therapeutics-announces-approval-of-clinical-trial-4xpj1gt0hg5d.html"
X Link 2026-02-04T13:52Z [----] followers, [---] engagements
"$MCK -Cowen raises McKesson target to $1012 from $1000 Buy -Wells Fargo raises target to $925 from $914 = Weight -Mizuho raises target to $885 from $880 Neutral - $MDLN -Tigress Financial initiates Medline coverage with a Buy rating $55 target -"
X Link 2026-02-06T00:59Z [----] followers, [---] engagements
"$SU -RBC raises Suncor target to $75 from $69 Outperform - $SWK -Barclays raises Stanley Black & Decker target to $100 from $89 Overweight -Goldman raises target to $84 from $78 Neutral - $SYM -Northland raises Symbotic target to $73 from $70 Outperform -"
X Link 2026-02-06T04:01Z [----] followers, [---] engagements
"$ZS Zscaler Acquires SquareX to Advance Zero Trust Browser Security for the AI Era https://www.stocktitan.net/news/ZS/zscaler-acquires-square-x-to-advance-zero-trust-browser-security-for-oktwviays8jd.html https://www.stocktitan.net/news/ZS/zscaler-acquires-square-x-to-advance-zero-trust-browser-security-for-oktwviays8jd.html"
X Link 2026-02-06T04:54Z [----] followers, [---] engagements
"$CGC Canopy Growth Reports Third Quarter Fiscal [----] Financial Results https://www.stocktitan.net/news/CGC/canopy-growth-reports-third-quarter-fiscal-2026-financial-2uussut0nvpi.html https://www.stocktitan.net/news/CGC/canopy-growth-reports-third-quarter-fiscal-2026-financial-2uussut0nvpi.html"
X Link 2026-02-06T15:20Z [----] followers, [---] engagements
"$AGI -Scotiabank raises Alamos Gold target to $60 from $55 Sector Outperform - $AIOT -Barrington Research reiterates PowerFleet $15 target Outperform - $AKBA -HC Wainwright maintains Akebia Therapeutics $6 target Buy -Piper Sandler lowers target to $4 from $6 Overweight -"
X Link 2026-02-06T20:46Z [----] followers, [---] engagements
"$EL -JPMorgan lowers Estee Lauder target to $121 from $131 Overweight -Citi upgrades to Buy from Neutral $120 target -Wells Fargo lowers target to $105 from $111 = Weight - $EMBC -BTIG maintains Embecta $25 target Buy -"
X Link 2026-02-07T20:37Z [----] followers, [---] engagements
"$SLAB -Citi raises Silicon Laboratories target to $231 from $135 Buy - $SLG -Goldman lowers SL Green Realty target to $37 from $42 Sell - $SLGN -Citi raises Silgan target to $56 from $47 Buy - $SLQT -Craig Hallum lowers SelectQuote target to $3 from $4 Buy -"
X Link 2026-02-09T00:17Z [----] followers, [---] engagements
"$TECH -Wells Fargo raises Bio-Techne target to $76 from $70 Overweight - $TNGX -Guggenheim raises Tango Therapeutics target to $18 from $12 Buy - $TPG -Barclays lowers TPG target to $69 from $78 Overweight -"
X Link 2026-02-09T01:25Z [----] followers, [---] engagements
"$EXPO -UBS raises Exponent target to $85 from $81 Neutral - $FIVE -Bernstein raises Five Below target to $206 from $195 arket Perform - $FLD -HC Wainwright maintains Fold $7 target Buy -"
X Link 2026-02-09T20:45Z [----] followers, [---] engagements
"$NUKK $DFNS Nukkleus Announces Corporate Rebranding: Changes Name to T3 Defense and Ticker Symbol to DFNS https://www.stocktitan.net/news/NUKK/nukkleus-inc-announces-corporate-rebranding-changes-name-to-t3-t5avt7b24vwu.html https://www.stocktitan.net/news/NUKK/nukkleus-inc-announces-corporate-rebranding-changes-name-to-t3-t5avt7b24vwu.html"
X Link 2026-02-09T21:08Z [----] followers, [---] engagements
"$TERN -Leerink initiates Terns Pharmaceuticals with an Outperform rating highlighting TERN-701 potential -Sets $58 target https://www.investing.com/news/analyst-ratings/leerink-partners-initiates-terns-pharmaceuticals-stock-with-outperform-rating-93CH-4493340 https://www.investing.com/news/analyst-ratings/leerink-partners-initiates-terns-pharmaceuticals-stock-with-outperform-rating-93CH-4493340"
X Link 2026-02-10T00:11Z [----] followers, [---] engagements
"$SOPH SOPHiA GENETICS Announces Major Expansion in the United States with the Signing of Two Major Integrated Health Systems https://www.stocktitan.net/news/SOPH/sop-hi-a-genetics-announces-major-expansion-in-the-united-states-64qejopypewv.html https://www.stocktitan.net/news/SOPH/sop-hi-a-genetics-announces-major-expansion-in-the-united-states-64qejopypewv.html"
X Link 2026-02-10T16:19Z [----] followers, [---] engagements
"$EVMN -HC Wainwright raises Evommune target to $65 from $35 Buy -Evercore raises target to $55 from $40 Outperform - $EXPE -Truist raises Expedia target to $252 from $210 Hold - $FDX -Barclays raises FedEx target to $450 from $360 Overweight -"
X Link 2026-02-11T00:24Z [----] followers, [---] engagements
"$WAT -Guggenheim maintains Waters $440 target Buy -Citi maintains $425 target Buy -Cowen maintains $400 target Buy -Barclays maintains $400 target Overweight -UBS lowers target to $370 from $395 Neutral -Baird lowers target to $363 from $398 Outperform -Evercore maintains $360 target In-Line - https://twitter.com/i/web/status/2021435028484563133 https://twitter.com/i/web/status/2021435028484563133"
X Link 2026-02-11T04:04Z [----] followers, [---] engagements
"$WDAY -UBS lowers Workday target to $170 from $240 Neutral - $WERN -UBS raises Werner Enterprises target to $33 from $25 Neutral - $WING -Cowen lowers Wingstop target to $285 from $310 Downgrades to Hold from Buy -"
X Link 2026-02-11T04:06Z [----] followers, [---] engagements
"$MDGL Madrigal Dives Further Into MASH With up to $4.4 siRNA Deal With Chinese Biotech https://www.biospace.com/deals/madrigal-dives-further-into-mash-with-up-to-4-4-sirna-deal-with-chinese-biotech https://www.biospace.com/deals/madrigal-dives-further-into-mash-with-up-to-4-4-sirna-deal-with-chinese-biotech"
X Link 2026-02-11T15:53Z [----] followers, [---] engagements
"Notable [--] Week Highs Cont. from Part [--] $FITB $FIX $FLS $FORM $FRO $FTI $FUL $FULT $GASS $GEF $GGG $GHM $GILD $GLDD $GNK $GNL $GNRC $GPRE $GRC $GTES $GTX $GVA $GWW $GXO $HAFN $HAS $HCSG $HLIO $HLT $HSHP $HST $HTLD Part [--] Cont. -"
X Link 2026-02-11T16:50Z [----] followers, [--] engagements
"$ZS -RBC lowers Zscaler target to $250 from $290 Outperform --"
X Link 2026-02-12T03:40Z [----] followers, [---] engagements
"$EXEL Zanzalintinib's second-wave push https://www.oncologypipeline.com/apexonco/zanzalintinibs-second-wave-push https://www.oncologypipeline.com/apexonco/zanzalintinibs-second-wave-push"
X Link 2026-02-12T16:24Z [----] followers, [---] engagements
"Notable [--] Week Lows $ABR $ACCS $ACN $ADBE $ADIL $ADP $ADSK $AEMD $AETE $AIOT $AISP $AJG $ALKT $AMPL $ANGI $AON $APPF $APPN $ARBK $ARX $ASAN $ASST $ASUR $ATOS $ATPC $BAH $BBSI $BCTX $BFAM $BIRD $BL $BMBL $BOX $BR $BRBR $BRZE $BWIN $CAI $CARL $CBZ $CCC $CDW $CERT Part [--] Cont. -"
X Link 2026-02-12T17:39Z [----] followers, [---] engagements
"$ACGL -Mizuho raises Arch Capital target to $102 from $95 Neutral - $ACLX -Rothschild Redburn downgrade Arcellx to Neutral from Buy Lower target to $82 from $113 - $AD -Wells Fargo lowers Array Digital target to $54 from $62 Overweight -"
X Link 2026-02-12T18:33Z [----] followers, [---] engagements
"$GPC -Truist raises Genuine Parts target to $162 from $146 Buy - $GRAB -Benchmark reiterates Grab Buy rating $7 target - $HAS -Citi raises Hasbro target to $118 from $97 Buy - $HD -Citi raises Home Depot target to $450 from $407 Buy -"
X Link 2026-02-12T21:53Z [----] followers, [---] engagements
"$HII -Bank of America upgrades Huntington Ingalls to Neutral from Underperform Raises target to $400 from $300 - $HLT -Argus raises Hilton Worldwide target to $380 from $350 Buy -Wells Fargo raises target to $373 from $338 Overweight -Barclays raises target to $350 from $309 Overweight -JPMorgan raises target to $350 from $318 Overweight -Evercore raises target to $335 from $325 In-Line -Mizuho raises target to $321 from $266 Neutral -Truist raises target to $307 from $253 Hold https://twitter.com/i/web/status/2022068036656935049 https://twitter.com/i/web/status/2022068036656935049"
X Link 2026-02-12T21:59Z [----] followers, [---] engagements
"$LSCC -Baird raises Lattice Semiconductor target to $120 from $75 Outperform - $LUXE -JPMorgan upgrades LuxExperience to Overweight from Neutral Raises target to $14 from $9 - $LYFT -Mizuho lowers Lyft target to $16 from $27 Neutral -Susquehanna lowers target to $15 from $24 Neutral - https://twitter.com/i/web/status/2022090787606213118 https://twitter.com/i/web/status/2022090787606213118"
X Link 2026-02-12T23:29Z [----] followers, [---] engagements
"$PEGA -Citi lowers Pegasystems target to $73 from $81 Buy -Wedbush lowers target to $65 from $80 Outperform -Rosenblatt maintains $62 target Buy -Citizens JMP lowers target to $59 from $78 Market Outperform - $PFE -Daiwa downgrades Pfizer to Neutral from Outperform $27 target"
X Link 2026-02-13T00:50Z [----] followers, [---] engagements
"$EVMN Evommune Announces $125 Million Private Placement https://www.stocktitan.net/news/EVMN/evommune-announces-125-million-private-55cq5g45aubi.html https://www.stocktitan.net/news/EVMN/evommune-announces-125-million-private-55cq5g45aubi.html"
X Link 2026-02-13T02:18Z [----] followers, [---] engagements
"Notable [--] Week Highs Cont. from Part [--] $TDS $TM $TNGX $TOL $TPH $TRP $UL $VAL $WES $WSR $YUM $ZGN Part [--] --"
X Link 2026-02-13T17:34Z [----] followers, [---] engagements
"$ALM -B. Riley raises Almonty Industries target to $17 from $10 Buy - $ALNY -Chardan Capital lowers Alnylam Pharmaceuticals target to $425 from $475 Buy - $AM -Wells Fargo raises Antero Midstream target to $21 from $20 = Weight -"
X Link 2026-02-13T18:22Z [----] followers, [---] engagements
"$ANET -Evercore raises Arista Networks target to $200 from $175 Outperform -Goldman raises target to $188 from $165' Buy -Needham raises target to $185 from $165 Buy -Wells Fargo raises target to $185 from $175 Overweight -Barclays raises target to $184 from $83 Overweight -KeyBanc raises target to $178 from $170 Overweight -UBS raises target to $177 from $155 Buy -Piper Sandler raises target to $175 from $159 Overweight -Morgan Stanley raises target to $165 from $159 Overweight = https://twitter.com/i/web/status/2022390374879404039 https://twitter.com/i/web/status/2022390374879404039"
X Link 2026-02-13T19:20Z [----] followers, [---] engagements
"$AVTR -Wells Fargo lowers Avantor target to $14 from $16 Overweight -Morgan Stanley lowers target to $10 from $12 = Weight - $AX -Needham reiterates Axos Financial $110 target Buy -"
X Link 2026-02-13T19:59Z [----] followers, [---] engagements
"$DKNG -Canaccord lowers DraftKings target to $44 from $50 Buy -BMO lowers target to $42 from $50 Outperform -BTIG lowers target to $37 from $45 Buy -Bank of America lowers target to $30 from $37.50 Neutral -Benchmark lowers target to $29 from $37 Buy -"
X Link 2026-02-14T00:29Z [----] followers, [---] engagements
"$AMGN Amgen receives EC approval for Uplizna in generalised myasthenia gravis via @PharmaTechFocus https://www.pharmaceutical-technology.com/news/amgen-ec-approval-uplizna-gmg/ https://www.pharmaceutical-technology.com/news/amgen-ec-approval-uplizna-gmg/"
X Link 2026-02-14T16:11Z [----] followers, [---] engagements
"$PLTR Palantir Finally Gets a Pentagon Green Light Wall Street Can't Ignore https://www.thestreet.com/investing/palantir-finally-gets-a-pentagon-green-light-wall-street-cant-ignore https://www.thestreet.com/investing/palantir-finally-gets-a-pentagon-green-light-wall-street-cant-ignore"
X Link 2026-02-15T03:40Z [----] followers, [---] engagements
"$NTES -Nomura lowers NetEase target to $155 from $160 Buy - $NVMI -Citi raises Nova target to $520 from $370 Buy -Evercore raises target to $485 from $340 Outperform -Morgan Stanley raises target to $453 from $335 = Weight - $NVR -UBS maintains NVR $8100 target Neutral -"
X Link 2026-02-15T17:58Z [----] followers, [--] engagements
"$ADVM Adverum Biotechnologies Announces Positive Preliminary Efficacy and Safety Data from LUNA Phase [--] Trial of Ixo-vec in Patients with Wet AMD BioSpace #jobs https://www.biospace.com/article/releases/adverum-biotechnologies-announces-positive-preliminary-efficacy-and-safety-data-from-luna-phase-2-trial-of-ixo-vec-in-patients-with-wet-amd/utm_source=socialmedia https://www.biospace.com/article/releases/adverum-biotechnologies-announces-positive-preliminary-efficacy-and-safety-data-from-luna-phase-2-trial-of-ixo-vec-in-patients-with-wet-amd/utm_source=socialmedia"
X Link 2024-02-08T14:32Z [----] followers, [---] engagements
"$SPRY - ARS Pharmaceuticals Announces FDA Approval of neffy [--] mg (epinephrine nasal spray) for Type I Allergic Reactions Including Anaphylaxis in Pediatric Patients Weighing [--] to [--] Kilograms - https://www.globenewswire.com/news-release/2025/03/05/3037769/0/en/ARS-Pharmaceuticals-Announces-FDA-Approval-of-neffy-1-mg-epinephrine-nasal-spray-for-Type-I-Allergic-Reactions-Including-Anaphylaxis-in-Pediatric-Patients-Weighing-15-to-30-Kilogra.html"
X Link 2025-03-05T22:30Z [----] followers, [---] engagements
"$IDXX -Morgan Stanley raises IDEXX Laboratories target to $765 from $722 Overweight - $INKT -HC Wainwright upgrades MiNK Therapeutics to Buy from Neutral $35 target - $INSP -Leekrink lowers Inspire Medical Systems target to $97 from $116 Market Perform -"
X Link 2025-08-15T23:02Z [----] followers, [---] engagements
"$ODFL -UBS raises Old Dominion Freight target to $164 from $155 Neutral - $OEC -Mizuho lowers Orion target to $7 from $9 Underperform - $OLN -Mizuho raises Olin target to $26 from $23 Neutral - $OSIS -Oppenheimer raises OSI Systems target to $280 from $270 Outperform -"
X Link 2025-10-04T23:59Z [----] followers, [---] engagements
"$MOS -UBS lowers Mosaic target to $44 from $46 Buy - $MSDL -Wells Fargo upgrades Morgan Stanley Direct Lending to Overweight from = Weight $17 target - $MSFT -Wells Fargo raises Microsoft target to $675 from $650 Overweight - $MTB -Piper Sandler initiates M&T Bank coverage at Overweight $225 target - https://twitter.com/i/web/status/1975360494493171832 https://twitter.com/i/web/status/1975360494493171832"
X Link 2025-10-07T00:40Z [----] followers, [---] engagements
"$TYL -Baird lowers Tyler Technologies target to $660 from $720 Outperform -Evercore to $575 from $595 In-Line -DA Davidson to $540 from $560 Neutral - $U -BTIG upgrades Unity to Neutral from Sell - $UPBD -Cowen lowers Unbound target to $31 from $36 Buy -BTIG to $28 from $40 Buy - https://twitter.com/i/web/status/1985183681238225268 https://twitter.com/i/web/status/1985183681238225268"
X Link 2025-11-03T03:14Z [----] followers, [---] engagements
"$WWW -Telsey maintains Wolverine World Wide $29 target Market Perform - $XEL -Barclays raises Xcel Energy target to $85 from $83 Overweight - $XFOR -Stifel lowers X4 Pharmaceuticals to $7.50 from $9 Buy - $XGN -B. Riley raises Exagen target to $18 from $15 Buy -"
X Link 2025-11-06T16:43Z [----] followers, [---] engagements
"$DCBO -Needham lowers Docebo target to $38 from $42 Buy - $DD -Wells Fargo lowers Dupont target to $50 from $100 Overweight -Citi raises target to $47 from $38 Buy -"
X Link 2025-11-08T18:36Z [----] followers, [---] engagements
"$ANTX $GSK AN2 Therapeutics Announces Research Collaboration With GSK to Advance Boron-Based LeuRS-Inhibitors Targeting Tuberculosis (TB) https://www.stocktitan.net/news/ANTX/an2-therapeutics-announces-research-collaboration-with-gsk-to-qn7lrnh9nnt8.html https://www.stocktitan.net/news/ANTX/an2-therapeutics-announces-research-collaboration-with-gsk-to-qn7lrnh9nnt8.html"
X Link 2025-11-10T16:41Z [----] followers, [---] engagements
"$TMCI -Truist lowers Treace Medical target to $4 from $7 Hold - $TNDM -Barclays raises Tandem Diabetes Care target to $55 from $50 Overweight -Morgan Stanley to $17 from $13 = Weight -Truist to $17 from $16 Hold - $TNYA -Chardan Capital maintains Tenaya Therapeutics $9 target Buy - https://twitter.com/i/web/status/1988068457154519383 https://twitter.com/i/web/status/1988068457154519383"
X Link 2025-11-11T02:17Z [----] followers, [---] engagements
"$ZBH -Canaccord lowers Zimmer Biomet target to $93 from $101 Hold - $ZD -UBS lowers Ziff Davis target to $38 from $40 Neutral -Citi to $35 from $42 Neutral -Barclays to $34 from $40 = Weight -"
X Link 2025-11-11T02:39Z [----] followers, [---] engagements
"$MGTX -Chardan Capital reiterates MeiraGTX $35 target Buy -Piper Sandler raises target to $30 from $28 Overweight - $MIDD -Barclays lowers Middleby target to $168 from $180 Overweight - $MLM -JPMorgan raises Martin Marietta target to $700 from $670 Overweight -Stifel to $681 from $637 Buy - https://twitter.com/i/web/status/1988309274226029020 https://twitter.com/i/web/status/1988309274226029020"
X Link 2025-11-11T18:14Z [----] followers, [---] engagements
"$VSAT -JPMorgan raises Viasat target to $50 from $23 Upgrades to Overweight from Neutral -Needham raises target to $45 from $25 Buy - $VYGR -Wedbush maintains Voyager Therapeutics $8 target Outperform - $WAY -Needham initiates Waystar coverage at Buy $46 target -"
X Link 2025-11-11T22:06Z [----] followers, [---] engagements
"$AVDL Avadel Receives Unsolicited Proposal from Lundbeck Avadel received an unsolicited proposal from H. Lundbeck A/S to acquire Avadel for up to $23.00 per share$21.00 cash at closing plus a non-transferable CVR worth up to $2.00 tied to U.S. net sales milestones for LUMRYZ and valiloxybate by [----] and [----]. Avadel noted the Lundbeck Proposal is subject to shareholder and regulatory approvals and closing conditions. The Avadel Board determined in good faith the Lundbeck Proposal would reasonably be expected to result in a Company Superior Proposal under its agreement with Alkermes permitting"
X Link 2025-11-14T15:33Z [----] followers, [---] engagements
"$HURN -Truist raises Huron target to $240 from $180 Buy - $HWM -Bank of America raises Howmet Aerospace target to $250 from $215 Buy - $IMUX -HC Wainwright lowers Immunic target to $8 from $10 Buy - $INO -Piper Sandler raises Inovio Pharmaceuticals target to $6 from $5 Overweight"
X Link 2025-11-15T20:05Z [----] followers, [---] engagements
"$VNT -Bank of America double-downgrades Vontier to Underperform from Buy Lowers target to $40 from $50 - $VOR -HC Wainwright lowers Vor Biopharma target to $32 from $50 Buy - $VRSK -Argus downgrades Verisk Analytics to Hold from Buy -"
X Link 2025-11-16T00:36Z [----] followers, [---] engagements
"$EXPO -William Blair upgrades Exponent to Outperform from Market Perform on strong Q3 results https://www.investing.com/news/analyst-ratings/william-blair-upgrades-exponent-stock-to-outperform-on-strong-q3-results-93CH-4361868 https://www.investing.com/news/analyst-ratings/william-blair-upgrades-exponent-stock-to-outperform-on-strong-q3-results-93CH-4361868"
X Link 2025-11-17T19:17Z [----] followers, [---] engagements
"$RCKT -Barclays lowers Rocket Pharmaceuticals target to $8 from $10 = Weight -JPMorgan downgrades to Underweight from Neutal - $RCL -Wells Fargo initiates Royal Caribbean coverage at Overweight $320 target - $REG -Barclays lowers Regency Centers target to $82 from $83 Upgrades to Overweight from = Weight -Truist lowers target to $77 from $81 Buy - https://twitter.com/i/web/status/1990964078999974003 https://twitter.com/i/web/status/1990964078999974003"
X Link 2025-11-19T02:03Z [----] followers, [---] engagements
"$RGLD -Cowen raises Royal Gold target to $263 from $261 Buy - $RPD -Berenberg Bank initiates Rapid7 coverage at Hold $16 target - $RRC -Piper Sandler lowers Range Resources target to $37 from $39 Neutral - $RRR -Wells Fargo initiates Red Rock Resources coverage at = Weight $58 target - https://twitter.com/i/web/status/1990964917000937545 https://twitter.com/i/web/status/1990964917000937545"
X Link 2025-11-19T02:06Z [----] followers, [---] engagements
"$UPB -Evercore initiates Upstream Bio coverage at Outperform $40 target - $VAC -Wells Fargo initiates Marriott Vacations coverage at Underweight $37 target - $VFC -Goldman lifts VF target to $16 from $15 Neutral -"
X Link 2025-11-19T03:36Z [----] followers, [---] engagements
"$GOCO -William Blair downgrades GoHealth to Market Perform from Outperform - $GOVX -D. Boral lowers GeoVax target to $6 from $9 Buy - $GTLB -Truist downgrades GitLab to Hold from Buy Lowers target to $44 from $55 -"
X Link 2025-11-19T18:48Z [----] followers, [---] engagements
"$ICFI -Barrington Research lowers ICF target to $102 from $107 Outperform - $IDA -Morgan Stanley lowers IDACORP target to $137 from $141 = Weight - $IIIV -DA Davidson lowers i3 Verticals target to $35 from $39 Buy - $INSM -Cowen raises Insmed target to $231 from $223 Buy -"
X Link 2025-11-20T23:18Z [----] followers, [---] engagements
"$ROK -Bank of America raises Rockwell Automation target to $430 from $410 Buy - $ROP -Piper Sandler initiates Roper Technologies coverage at Overweight $600 target - $RRR -Citi initiates Red Rock Resorts coverage at Buy $63 target -"
X Link 2025-11-21T02:19Z [----] followers, [---] engagements
"$EVH -Citi lowers Evolent Health target to $9.50 from $11.50 Buy - $EXPGY -Citi upgrades Experian to Buy from Neutral Lowers target to $3907 GBp from [----] GBp - $FRO -Jefferies raises Frontline target to $30 from $28 Buy - $FUL -UBS initiates H.B. Fuller coverage at Neutral $60 target - https://twitter.com/i/web/status/1992359277743456491 https://twitter.com/i/web/status/1992359277743456491"
X Link 2025-11-22T22:27Z [----] followers, [---] engagements
"$LSPD Lightspeed Commerce Unveils Tempo a New Pacing Intelligence for Restaurants Lightspeed's Tempo is a pacing intelligence built into Lightspeed Restaurant that uses real-time dining flow data to guide servers and managers through service moments. Tempo aims to make pacing measurable and coachable to improve guest experience increase table turns and boost staff performance. The product is available to Lightspeed Restaurant customers and will expand connectivity with Lightspeed systems such as Kitchen Display and Pulse."
X Link 2025-11-24T17:47Z [----] followers, [---] engagements
"$ASML -UBS raises ASML target to [----] from [----] Buy - $AVB -Barclays upgrades AvalonBay to Overweight from = Weight Lowers target to $216 from $229 - $AVBP -Truist initiates Arrivent BioPharma coverage at Buy on lung cancer drug $43 target https://www.investing.com/news/analyst-ratings/arrivent-biopharma-stock-initiated-with-buy-rating-at-truist-on-lung-cancer-drug-93CH-4376958 https://www.investing.com/news/analyst-ratings/arrivent-biopharma-stock-initiated-with-buy-rating-at-truist-on-lung-cancer-drug-93CH-4376958"
X Link 2025-11-25T17:40Z [----] followers, [----] engagements
"$GILT -Needham reiterates Gilat Satellite $16 target Buy - $GOOGL -MoffettNathanson raises Alphabet target to $315 from $305 Buy - $GSHD -BMO lowers Goosehead Insurance target to $79 from $110 Market Perform - $GSK -Bank of America upgrades GSK to Neutral from Underperform -"
X Link 2025-11-25T19:22Z [----] followers, [---] engagements
"$IMA -Wedbush assumes Imagene Bio coverage at Underperform $2 target - $IMAX -Goldman raises IMAX target to $34 from $22 Upgrades to Neutral from Sell - $INSP -Wolfe Research upgrades Inspire Medical Systems to Outperform from Peer Perform $180 target - $INVH -Barclays lowers Invitation Homes target to $34 from $37 Overweight - https://twitter.com/i/web/status/1993430827204780455 https://twitter.com/i/web/status/1993430827204780455"
X Link 2025-11-25T21:25Z [----] followers, [---] engagements
"$VERA -Cantor Fitzgerald reiterates Vera Therapeutics $100 target Overweight - $VG -JPMorgan lowers Venture Global target to $10 from $16 Overweight - $VITL -Mizuho lowers Vital Farms target to $48 from $53 Outperform - $VNRX -D. Boral maintains VolitionRx $5 target Buy -"
X Link 2025-11-27T02:45Z [----] followers, [---] engagements
"$NVDA $KYCCF $ISRG $TER $ZBRA US News & World Report: [--] Best Robotics Stocks to Buy Right Now https://money.usnews.com/investing/articles/5-best-robotics-stocks-to-buy-right-nowsrc=usn_tw https://money.usnews.com/investing/articles/5-best-robotics-stocks-to-buy-right-nowsrc=usn_tw"
X Link 2025-11-27T15:39Z [----] followers, [---] engagements
"$PK -Wells Fargo lowers Park Hotels target to $11 from $12 = Weight - $PMN -HC Wainwright raises Promis Neurosciences target to $18 from $4 Buy - $POST -Mizuho lowers Post target to $120 from $122 Outperform - $PRAX -Needham reiterates Praxis Precision Medicines $250 target Buy -"
X Link 2025-12-01T22:51Z [----] followers, [---] engagements
"$PRTA -Citizens JMP raises Prothena target to $19 from $11 Market Outperform - $PSA -Evercore lowers Public Storage target to $309 from $315 In-Line - $PSIX -Jefferies intiates Power Solutions coverage at Buy $110.51 target https://www.investing.com/news/analyst-ratings/jefferies-initiates-coverage-on-power-solutions-stock-with-buy-rating-93CH-4382925 https://www.investing.com/news/analyst-ratings/jefferies-initiates-coverage-on-power-solutions-stock-with-buy-rating-93CH-4382925"
X Link 2025-12-01T22:55Z [----] followers, [---] engagements
"$CRDO -Roth raises Credo Technology target to $250 from $170 Buy -Bank of America to $240 from $165 Buy -Cowen to $240 from $190 Buy -KGI upgrades to Outperform from Neutral $230 target -Mizuho raises target to $225 from $165 Outperform -Barclays to $220 from $165 Overweight -Needham to $220 from $190 Buy - https://twitter.com/i/web/status/1995886409333571984 https://twitter.com/i/web/status/1995886409333571984"
X Link 2025-12-02T16:02Z [----] followers, [---] engagements
"$MH -BTIG raises McGraw Hill target to $22 from $19 Buy - $MRK -Goldman raises Merck & Co. target to $120 from $92 Buy - $MTD -Morgan Stanley initiates Mettler-Toledo coverage at = Weight $1550 target - $MU -Wolfe Research raises Micron target to $300 from $200 Outperform -"
X Link 2025-12-02T23:01Z [----] followers, [---] engagements
"$ADCT ADC Therapeutics Announces Updated Data from LOTIS-7 Phase 1b Clinical Trial of ZYNLONTA in Combination with Bispecific Antibody Supporting Potential Best-in-Class Regimen in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma https://www.stocktitan.net/news/ADCT/adc-therapeutics-announces-updated-data-from-lotis-7-phase-1b-8wrbog1mx5kb.html https://www.stocktitan.net/news/ADCT/adc-therapeutics-announces-updated-data-from-lotis-7-phase-1b-8wrbog1mx5kb.html"
X Link 2025-12-03T15:07Z [----] followers, [---] engagements
"$NBP NovaBridge Announces Presentation of Ragistomig Expanded Phase [--] Data at ESMO-IO - Ragistomig is a 4-1BB X PD-L1 bispecific antibody designed to treat patients who are relapsed or refractory to checkpoint inhibitors a multi-billion dollar drug class hampered by widespread resistance - Phase [--] ragistomig study achieved its objective as the new Q6W extended dosing interval produced strong anti-tumor efficacy in PD-L1-non-responders with an improved safety profile - The interim results including immunological data on CD8+ cell proliferation and memory T-cell activation are expected to be"
X Link 2025-12-04T05:03Z [----] followers, [---] engagements
"$ORIC $AVBP $BDTX $BAYRY ESMO Asia [----] Orics first-line gamble https://www.oncologypipeline.com/apexonco/esmo-asia-2025-orics-first-line-gamble https://www.oncologypipeline.com/apexonco/esmo-asia-2025-orics-first-line-gamble"
X Link 2025-12-05T14:36Z [----] followers, [---] engagements
"$AGX -Lake Street lifts Argan target to $325 from $260 Downgrades to Hold from Buy - $AIG -Barclays lowers American International Group target to $88 from $95 Downgrades to = Weight from Overweight - $AJG -Wells Fargo lowers Arthur J. Gallagher target to $344 from $362 Overweight"
X Link 2025-12-05T17:10Z [----] followers, [---] engagements
"$HQY -Deutsche Bank raises HealthEquity target to $120 from $117 Buy - $HRL -JPMorgan raises Hormel Foods target to $28 from $27 Overweight -Bank of America Piper Sandler lift target to $26 from $25 Neutral -"
X Link 2025-12-06T00:32Z [----] followers, [---] engagements
"$PEGA -JPMorgan raises Pegasystems target to $74 from $65 Overweight - $PKG -JPMorgan raises Packaging Corp of America target to $245 from $238 Overweight - $PLAY -UBS lowers Dave & Busters target to $20 from $25 Neutral -"
X Link 2025-12-06T20:43Z [----] followers, [---] engagements
"$RHI -BNP Paribas downgrades Robert Half to Underperform from Neutral $22 target - $RNR -BMO raises RenaissanceRe target to $303 from $294 Outperform - $ROL -Barclays raises Rollins target to $72 from $60 Upgrades to Overweight from = Weight -"
X Link 2025-12-06T23:22Z [----] followers, [---] engagements
"$VERA -Cowen raises Vera Therapeutics target to $73 from $60 Buy - $VITL -Needham initiates Vital Farms coverage with a Buy rating $45 target - $VRTX -Morgan Stanley raises Vertex Pharmaceuticals target to $564 from $516 Overweight -"
X Link 2025-12-07T00:43Z [----] followers, [---] engagements
"$APTV -Morgan Stanley raises Aptiv target to $84 from $60 Upgrades to = Weight from Underweight - $AR -JPMorgan lowers Antero Resources target to $39 from $44 Downgrades to Neutral from Overweight - $ARGX -JPMorgan raises argenx target to $1100 from $925 Overweight -"
X Link 2025-12-08T17:10Z [----] followers, [---] engagements
"$FVR -Morgan Stanley raises FrontView REIT target to $17 from $15 = Weight - $GEN -Benchmark reiterates Genius Sports $16 target Buy - $GLTO -Guggenheim raises Alecto target to $36 from $32 Buy -"
X Link 2025-12-08T21:41Z [----] followers, [---] engagements
"$HTLD -Morgan Stanley lowers Heartland Express target to $8 from $10 = Weight - $HUBG -Morgan Stanley raises Hub Group target to $46 from $44 = Weight - $ICG -Benchmark reiterates Intchaiuns $4 target Buy - $IEX -Citi raises IDEX target to $202 from $197 Buy -"
X Link 2025-12-08T21:51Z [----] followers, [---] engagements
"$WAY -Barclays lowers Waystar target to $42 from $50 Overweight - $WERN -Morgan Stanley raises Werner target to $37 from $36 Overweight - $WMS -Barclays raises Advanced Drainage Systems target to $181 from $176 Overweight - $WPC -RBC downgrades W.P. Carey to Sector Perform from Outperform $69 target - https://twitter.com/i/web/status/1998213539774058906 https://twitter.com/i/web/status/1998213539774058906"
X Link 2025-12-09T02:10Z [----] followers, [---] engagements
"$AMPH -Barclays initiates Amphastar Pharmaceuticals coverage at = Weight $30 target - $ANIP -Barclays initiates ANI Pharmaceuticals coverage at Overweight $100 target - $APTV -Wells Fargo trims Aptiv target to $99 from $100 Overweight -"
X Link 2025-12-09T16:53Z [----] followers, [---] engagements
"$HLIT -Needham reiterates Harmonic $15 target Buy -Rosenblatt maintains $14 target Buy - $HRL -Barclays lowers Hormel Foods target to $30 from $31 Overweight - $IBM -Stifel raises International Business Machines target to $325 from $295 Buy -UBS maintains $210 target Sell -"
X Link 2025-12-09T18:02Z [----] followers, [---] engagements
"$MTD -Goldman initiates Mettler-Toledo coverage at Neutral $1475 target - $MTN -Deutsche Bank raises Vail Resorts target to $162 from $159 Hold - $MU -HSBC Initiates Micron coverage with a Buy rating $330 target -Deutsche Bank lifts target to $280 from $200 Buy -"
X Link 2025-12-09T23:00Z [----] followers, [---] engagements
"$RCL -Goldman lowers Royal Caribbean target to $275 from $334 Buy - $RDDT -China Renaissance initiates Reddit coverage with a Buy rating $300 target - $RELX -Deutsche Bank upgrades Relx to Buy from Hold Raises target to 340p from 300p - $RL -Guggenheim initiates Ralph Lauren coverage with a Neutral rating - https://twitter.com/i/web/status/1998547442237927536 https://twitter.com/i/web/status/1998547442237927536"
X Link 2025-12-10T00:16Z [----] followers, [---] engagements
"$SW -Argus lowers Smurfit Westrock target to $45 from $55 Buy - $TDOC -Barclays initiates Teladov Health coverage at = Weight $8.50 target - $TDUP -Telsey maintains ThredUp $12 target Outperform - $TEL -Wells Fargo raises TE Connectivity target to $245 from $241 = Weight -"
X Link 2025-12-10T00:39Z [----] followers, [---] engagements
"$AVBP -BTIG initiates ArriVent Biopharma coverage with a Buy rating on oncology potential -Sets $45 target https://www.investing.com/news/analyst-ratings/arrivent-biopharma-stock-initiated-with-buy-rating-at-btig-on-oncology-potential-93CH-4400739 https://www.investing.com/news/analyst-ratings/arrivent-biopharma-stock-initiated-with-buy-rating-at-btig-on-oncology-potential-93CH-4400739"
X Link 2025-12-10T17:01Z [----] followers, [---] engagements
"$EVMN Evommune Reports Third Quarter [----] Financial Results and Provides Business Update - Three Phase [--] data readouts from lead programs EVO756 and EVO301 expected in [----] across atopic dermatitis (AD) and chronic spontaneous urticaria (CSU) - Well capitalized to deliver on key milestones following completion of initial public offering (IPO) raising $172.5 million in gross proceeds including the full exercise of the underwriters option to purchase additional shares https://www.stocktitan.net/news/EVMN/evommune-reports-third-quarter-2025-financial-results-and-provides-h8932yz59oe2.html"
X Link 2025-12-11T21:08Z [----] followers, [---] engagements
"$NTSK Netskope Announces Strong Third Quarter Fiscal Year [----] Financial Results - ARR increased 34% year-over-year to $754 million - Q3 revenue increased 33% year-over-year to $184.2 million - Surpassed $1 billion in Remaining Performance Obligations reflecting 41% year-over-year growth - Q3 net cash provided by operating activities was $11.2 million representing 6% of revenue - Q3 free cash flow was $10.6 million representing a positive 6% free cash flow margin https://www.stocktitan.net/news/NTSK/netskope-announces-strong-third-quarter-fiscal-year-2026-financial-qra3o1f119g4.html"
X Link 2025-12-11T21:15Z [----] followers, [---] engagements
"$LBRX -Stifel raises LB Pharmaceuticals target to $35 from $27 Buy - $LEG -Piper Sandler lifts Leggett & Platt target to $12 from $10 Neutral - $LII -Barclays lowers Lennox target to $680 from $700 Overweight - $LNG -Bank of America lowers Cheniere Energy target to $271 from $274 Buy https://twitter.com/i/web/status/1999253954048512060 https://twitter.com/i/web/status/1999253954048512060"
X Link 2025-12-11T23:04Z [----] followers, [---] engagements
"$ALNY $FER $INSM $MPWR $STX $WDC $BIIB $CDW $GFS $LULU $ON $TTD Annual Changes to the Nasdaq-100 Index Six companies will be added: Alnylam Ferrovial Insmed Monolithic Power Systems Seagate Western Digital. Six companies will be removed: Biogen CDW GlobalFoundries Lululemon ON Semiconductor The Trade Desk. The Nasdaq-100 underpins more than [---] tracking products with over $600 billion in assets under management including the Invesco QQQ Trust ( $QQQ ). https://www.stocktitan.net/news/NDAQ/annual-changes-to-the-nasdaq-100-g69h3ryr3q2d.html"
X Link 2025-12-13T01:50Z [----] followers, [---] engagements
"$NOG -Mizuho raises Northern Oil target to $30 from $28 Neutral - $NTSK -KeyBanc raises Netskope target to $28 from $27 Overweight -Piper Sandler reiterates $28 target Overweight -RBC raises target to $27 from $26 Outperform -Deutsche Bank to $26 from $25 Buy -Mizuho to $26 from $25 Outperform - https://twitter.com/i/web/status/2000019704149315678 https://twitter.com/i/web/status/2000019704149315678"
X Link 2025-12-14T01:47Z [----] followers, [---] engagements
"$RHI -Truist lowers Robert Half target to $35 from $50 Buy - $RIVN -Needham raises Rivian target to $23 from $14 Buy -Goldman lifts target to $16 from $13 Neutral - $RL -Jefferies raises Ralph Lauren target to $425 from $385 Buy -"
X Link 2025-12-14T16:25Z [----] followers, [---] engagements
"$VNO -Mizuho lowers Vornado Realty target to $40 from $43 Outperform - $VNOM -Mizuho lifts Viper Energy target to $52 from $51 Buy - $VRTS -Barclays lowers Virtus target to $158 from $175 Underweight - $VTLE -Mizuho raises Vital Energy target to $23 from $21 Neutral -"
X Link 2025-12-14T17:12Z [----] followers, [---] engagements
"$LMRI Lumexa Imaging tallies $462.5M in IPO doubling original target https://www.fiercebiotech.com/medtech/lumexa-imaging-tallies-4625m-ipo-doubling-its-original-target https://www.fiercebiotech.com/medtech/lumexa-imaging-tallies-4625m-ipo-doubling-its-original-target"
X Link 2025-12-15T16:01Z [----] followers, [---] engagements
"$IAC -Oppenheimer downgrades IAC to Market Perform from Outperform - $IBP -Jefferies raises Installed Business Products target to $259 from $230 Hold - $ICLR -Barclays raises Icon target to $200 from $185 = Weight -Bank of America lowers target to $195 from $207 Downgrades to Neutral from Buy - https://twitter.com/i/web/status/2000696278238519545 https://twitter.com/i/web/status/2000696278238519545"
X Link 2025-12-15T22:35Z [----] followers, [---] engagements
"$MRK -Bank of America raises Merck & Co. target to $120 from $105 Buy - $MRVI -Wells Fargo raises Maravai Life Sciences target to $4.50 from $4 Overweight - $MSFT -Wolfe Research lowers Microsoft target to $625 from $675 Outperform - $MSGE $MSGS -Wolfe Research downgrades Madison Square Garden Entertainment and Madison Square Sports to Peer Perform from Outperform - https://twitter.com/i/web/status/2000738330187796951 https://twitter.com/i/web/status/2000738330187796951"
X Link 2025-12-16T01:22Z [----] followers, [---] engagements
"$POOL -Wells Fargo lowers Pool target to $250 from $320 = Weight - $PRAX -Oppenheimer raises Praxis Precision Medicines target to $750 from $250 Outperform - $PRGO -JPMorgan lowers Perrigo target to $18 from $20 Neutral - $PRI -Morgan Stanley lowers Primerica target to $292 from $301 = Weight - https://twitter.com/i/web/status/2000746388553130323 https://twitter.com/i/web/status/2000746388553130323"
X Link 2025-12-16T01:54Z [----] followers, [---] engagements
"$UNM -Morgan Stanley raises Unum target to $85 from $81 = Weight - $USAU -Roth raises USA Gold target to $26 from $20 Buy - $VIK -Jefferies raises Viking target to $80 from $60 Upgrades to Buy from Hold - $VNO -Evercore trims Vornado Realty target to $42 from $43 Outperform -"
X Link 2025-12-16T03:46Z [----] followers, [---] engagements
"$WELL -Jefferies raises Welltower target to $231 from $210 Buy - $WGS -Wells Fargo raises GeneDx target to $155 from $140 = Weight - $WH -Goldman lowers Wyndham Hotels target to $76 from $88 Downgrades to Neutral from Buy - $WMG -Wolfe research lowers Warner Music Group target to $36 from $40 Outperform - https://twitter.com/i/web/status/2000775939983335592 https://twitter.com/i/web/status/2000775939983335592"
X Link 2025-12-16T03:52Z [----] followers, [---] engagements
"$MPLT MapLight brightens SandboxAQ with new deal to discover new CNS candidates https://www.fiercebiotech.com/biotech/maplight-brightens-sandboxaq-200m-deal-discover-new-cns-candidates https://www.fiercebiotech.com/biotech/maplight-brightens-sandboxaq-200m-deal-discover-new-cns-candidates"
X Link 2025-12-16T15:41Z [----] followers, [---] engagements
"$INBX Inhibrx Biosciences Provides Progress Updates on the INBRX-106 Program and the Expansion Cohorts of the ozekibart (INBRX-109) Program - INBRX-106 has enrolled [--] of [--] randomized patients in the Phase [--] portion for first-line unresectable/metastatic HNSCC and expects to finish Phase [--] enrollment in Q1 [----]. - A separate Phase 1/2 checkpoint inhibitor refractory/relapsed NSCLC cohort completed enrollment at [--] patients in November [----]. - Current datasets lack maturity to support conclusions; maturity expected in 2H [----] to inform efficacy versus standard of care. - Ozekibart (INBRX-109)"
X Link 2025-12-16T22:19Z [----] followers, [---] engagements
"$CTVA -Goldman raises Corteva target to $78 from $77 Buy - $CUBE -Truist lowers CubeSmart target to $42 from $48 Buy - $CW -Morgan Stanley raises Curtiss-Wright target to $660 from $645 Overweight -Stifel lowers target to $584 from $587 Hold - g"
X Link 2025-12-16T23:37Z [----] followers, [---] engagements
"$MDT -Baird lowers Medtronic target to $103 from $109 Neutral - $MIRM -Stifel raises Mirum Pharmaceuticals target to $98 from $92 Buy - $MIST -Wells Fargo raises Milestone Pharmaceuticals target to $8 from $4 Overweight - $MKSI -Cantor Fitzgerald raises MKS target to $200 from $180 Overweight - https://twitter.com/i/web/status/2001110485417205988 https://twitter.com/i/web/status/2001110485417205988"
X Link 2025-12-17T02:01Z [----] followers, [---] engagements
"$PAL -Stifel raises Proficient Auto Logistics target to $12 from $11 Buy - $PANW -Mizuho lowers Palo Alto Networks target to $220 from $230 Outperform - $PCTY -BTIG starts Paylocity coverage at Buy $180 target - $PEN -Baird raises Penumbra target to $345 from $310 Outperform -"
X Link 2025-12-17T03:55Z [----] followers, [---] engagements
"$RCT -Roth lowers Red Cloud target to $4.50 from $5 Buy - $REAL -Wells Fargo raises RealReal target to $20 from $15 Overweight - $RGTI -Jefferies initiates Rigetti Computing coverage at Hold $30 target - $RL -Wells Fargo raises Ralph Lauren target to $400 from $385 Overweight -"
X Link 2025-12-17T04:41Z [----] followers, [---] engagements
"$ROST -Wells Fargo raises Ross Stores target to $200 from $180 Overweight - $RPD -Jefferies trims Rapid7 target to $18 from $19 Hold - $RSI -Susquehanna lifts Rush Street target to $23 from $22 Positive - $RXO -Stifel lifts RXO target to $16 from $15 Hold -"
X Link 2025-12-17T04:48Z [----] followers, [---] engagements
"$VMI -Stifel raises Valmont Industries target to $491 from $475 Buy - $VNO -Truist lowers Vornado Realty target to $36 from $40 Hold - $VSCO -Wells Fargo raises Victoria's Secret target to $45 from $36 Upgrades to = Weight from Underweight -"
X Link 2025-12-17T05:16Z [----] followers, [---] engagements
"$WYFI -Compass Point initiates WhiteFiber coverage with a Buy rating $32 target - $XPO -Stifel raises XPO target to $167 from $149 Buy - $XRAY -Barrington Research lowers Dentsply Sirona target to $14 from $18 Outperform -Baird trims target to $12 from $14 Neutral -"
X Link 2025-12-17T05:43Z [----] followers, [---] engagements
"$NYXH Nyxoah Announces Commercial Launch of Genio Breakthrough Therapy in the Netherlands - First Genio implants successfully performed at OLVG West and Zuyderland hospitals https://www.stocktitan.net/news/NYXH/nyxoah-announces-commercial-launch-of-genio-breakthrough-therapy-in-l4glybk0sir9.html https://www.stocktitan.net/news/NYXH/nyxoah-announces-commercial-launch-of-genio-breakthrough-therapy-in-l4glybk0sir9.html"
X Link 2025-12-17T06:09Z [----] followers, [---] engagements
"$WST West Pharmaceutical Services Stock: Is WST Underperforming the Healthcare Sector via @Barchart https://www.barchart.com/share/news/36670736/west-pharmaceutical-services-stock-is-wst-underperforming-the-healthcare-sector https://www.barchart.com/share/news/36670736/west-pharmaceutical-services-stock-is-wst-underperforming-the-healthcare-sector"
X Link 2025-12-17T16:32Z [----] followers, [---] engagements
"$APP -BTIG raises AppLovin target to $771 from $705 Buy - $ARGX -RBC raises argenx target to $925 from $860 Outperform - $ARMK -Morgan Stanley lifts Aramark target to $44 from $43 = Weight - $ARVN -Barclays raises Arvinas target to $18 from $16 Overweight -"
X Link 2025-12-17T18:32Z [----] followers, [---] engagements
"$ASML -Barclays maintains ASML at Neutral - $ATO -UBS raises Atmos Energy target to $174 from $159 Neutral - $AVTR -Jefferies cuts Avantor target to $9 from $12 Downgrades to Underperform from Hold - $AWK -Barclays lowers American Water Works target to $122 from $134 Underweight"
X Link 2025-12-17T18:40Z [----] followers, [---] engagements
"$ATR $MIST Aptars Bidose Nasal System Delivers CARDAMYST (etripamil) the First and Only Self-Administered FDA-Approved Nasal Spray for Paroxysmal Supraventricular Tachycardia (PSVT) https://www.stocktitan.net/news/ATR/aptar-s-bidose-nasal-system-delivers-cardamysttm-etripamil-the-first-wstwdfyod4k8.html https://www.stocktitan.net/news/ATR/aptar-s-bidose-nasal-system-delivers-cardamysttm-etripamil-the-first-wstwdfyod4k8.html"
X Link 2025-12-17T22:03Z [----] followers, [---] engagements
"$RCT RedCloud Delivers Record [----] Executes $50m Turkiye License and Accelerates Toward $100m Revenue in [----] https://www.stocktitan.net/news/RCT/red-cloud-delivers-record-2025-executes-50m-turkiye-license-and-kmysebzdhn4o.html https://www.stocktitan.net/news/RCT/red-cloud-delivers-record-2025-executes-50m-turkiye-license-and-kmysebzdhn4o.html"
X Link 2025-12-17T22:12Z [----] followers, [---] engagements
"$MH -Morgasn Stanley raises McGraw Hill target to $21 from $20 Overweight - $MKSI -Mizuho raises MKS target to $195 from $175 Outperform - $MKTX -Argys lowers MarketAxess target to $205 from $212 Buy - $MMSI -Canaccord raises Merit Medical Systems target to $99 from $93 Buy -"
X Link 2025-12-18T01:48Z [----] followers, [---] engagements
"$SMMT -Barclays raises Summit Therapeutics target to $18 from $16 Upgrades to = Weight from Underweight - $SMWB -Oppenheimer lowers Similarweb target to $10 from $12 Outperform - $SNX -Morgan Stanley lowers TD SYNNEX target to $177 from $181 Overweight -"
X Link 2025-12-18T03:32Z [----] followers, [---] engagements
"$TDC -Morgan Stanley raises Teradata target to $35 from $30 Overweight - $TEF -New Street downgrades Telefonica to Reduce from Neutral [----] target - $TENX -Guggenheim maintains Tenax Therapeutics $25 target Buy -"
X Link 2025-12-18T03:53Z [----] followers, [---] engagements
"$ULTA -Baird raises Ulta Beauty target to $700 from $670 Outperform - $UPB -Mizuho starts Upstream Bio coverage at Outperform -Sets $51 target http://www.streetinsider.com/Analyst+Comments/Mizuho+Starts+Upstream+Bio+%28UPB%29+at+Outperform/25752815.html http://www.streetinsider.com/Analyst+Comments/Mizuho+Starts+Upstream+Bio+%28UPB%29+at+Outperform/25752815.html"
X Link 2025-12-18T04:09Z [----] followers, [---] engagements
"$VITL -Benchmark reiterates Vital Farms $60 target Buy -DA Davidson Jefferies maintain $52 target Buy -Telsey maintains $50 target Outperform -Morgan Stanley lowers target to $45 from $48 Overweight -"
X Link 2025-12-18T04:50Z [----] followers, [---] engagements
"$XEL -UBS lowers Xcel Energy target to $81 from $86 Neutral - $XNCR -Barclays raises Xencor target to $26 from $23 Overweight - $YOU -Telsey raises Clear Secure target to $45 from $38 Outperform - $ZYME -Truist reiterates Zymeworks Buy rating $40 target --"
X Link 2025-12-18T05:19Z [----] followers, [---] engagements
"$OMDA -Morgan Stanley names Omaha Health as top pick in healthcare technology Raises target to $32 from $30 Overweight - $ORA -Piper Sandler raises Ormat target to $125 from $102 Overweight - $ORKA -Piper Sandler initiates Oruka Therapeutics coverage at Overweight $75 target -"
X Link 2025-12-19T05:22Z [----] followers, [---] engagements
"$PRCT -Truist lowers PROCEPT BioRobotics target to $47 from $50 Buy - $PSA -JPMorgan lowers Public Storage target to $301 from $316 Downgrades to Neutral from Overweight - $PYXS -RBC lowers Pyxis Oncology target to $5 from $8 Outperform -"
X Link 2025-12-19T05:32Z [----] followers, [---] engagements
"$WLK -Citi raises Westlake target to $85 from $75 Buy - $ZBRA -Truist lowers Zebra Technologies target to $291 from $331 Hold - $ZS -Morgan Stanley lowers Zscaler target to $305 from $335 Overweight - $ZTS -Morgan Stanley lowers Zoetis target to $160 from $175 Overweight --"
X Link 2025-12-19T06:33Z [----] followers, [---] engagements
"$AMPL -Baird lifts Amplitude target to $15 from $14 Outperform - $APD -Wells Fargo lowers Air Products target to $250 from $330 Downgrades to = Weight from Overweight - $APH -Truist raises Amphenol target to $180 from $147 Buy -"
X Link 2025-12-20T16:01Z [----] followers, [---] engagements
"$CE -Wells Fargo lowers Celanese target to $45 from $55 Downgrades to = Weight from Overweight - $CELH -Bank of American lowers Celsius target to $45 from $50 Underperform - $CMCSA -BNP Paribas raises Comcast target to $30 from $28 Neutral - $CMG -Evercore maintains Chipotle Mexican Grill $45 target Outperform - https://twitter.com/i/web/status/2002444288341491931 https://twitter.com/i/web/status/2002444288341491931"
X Link 2025-12-20T18:21Z [----] followers, [---] engagements
"$UNFI -Wells Fargo lowers United Natural Foods target to $35 from $37 = Weight - $UWMC -Jefferies starts UWM coverage with a Hold rating $5 target - $VERA -JPMorgan raises Vera Therapeutics target to $96 from $49 Overweight -Goldman to $95 from $55 Buy -Bank of America to $66 from $48 Buy - https://twitter.com/i/web/status/2002522039471501711 https://twitter.com/i/web/status/2002522039471501711"
X Link 2025-12-20T23:30Z [----] followers, [---] engagements
"$NRSN NeuroSense Confirms Favorable Safety and Tolerability of PrimeC in an Alzheimer's Phase [--] Study https://www.stocktitan.net/news/NRSN/neuro-sense-confirms-favorable-safety-and-tolerability-of-prime-c-in-8n8235n1xzgg.html https://www.stocktitan.net/news/NRSN/neuro-sense-confirms-favorable-safety-and-tolerability-of-prime-c-in-8n8235n1xzgg.html"
X Link 2025-12-22T15:45Z [----] followers, [---] engagements
"$AVBP ArriVent Announces First Patient Dosed in Global Pivotal Phase [--] ALPACCA Trial Evaluating Firmonertinib for First-Line Treatment of EGFR PACC Mutant Non-Small Cell Lung Cancer https://www.stocktitan.net/news/AVBP/arri-vent-announces-first-patient-dosed-in-global-pivotal-phase-3-barausvltxil.html https://www.stocktitan.net/news/AVBP/arri-vent-announces-first-patient-dosed-in-global-pivotal-phase-3-barausvltxil.html"
X Link 2025-12-22T15:59Z [----] followers, [---] engagements
"$ADEA -Roth reiterates Adeia $27 target Buy -Rosenblatt raises target to $20 from $17 Buy - $AFL -Cowen raises Aflac target to $102 from $100 Hold - $AGNC -Piper Sandler raises AGNC Investment target to $11 from $10.50 Overweight -"
X Link 2025-12-22T20:39Z [----] followers, [---] engagements
"$DKNG -Truist lowers DraftKings target to $43 from $45 Buy - $DNTH -Wedbush reiterates Diantheus Therapeutics $46 target Outperform - $EGP -Evercore raises EastGroup Properties target to $185 from $183 In-Line - $ELF -Piper Sandler lowers e.l.f. Beauty target to $85 from $100 Neutral - https://twitter.com/i/web/status/2003225228173029868 https://twitter.com/i/web/status/2003225228173029868"
X Link 2025-12-22T22:04Z [----] followers, [---] engagements
"$FITB -Truistr raises Fifth Third Bank target to $55 from $50 Buy - $FLUT -Truist lowers Flutter Entertainment target to $280 from $305 Buy - $FMC -KeyBanc maintains FMC Sector Weight rating - $FN -Northland raises Fabrinet target to $600 from $550 Outperform -"
X Link 2025-12-22T22:09Z [----] followers, [---] engagements
"$KRMD -Lake Street raises KORU Medical Systems target to $8 from $6 Buy - $KYMR -B. Riley raises Kymera Therapeutics target to $117 from $80 Buy - $LEU -Needham maintains Centrus Energy $357 target Buy -B. Riley raises target to $315 from $221 Buy -"
X Link 2025-12-22T23:38Z [----] followers, [---] engagements
"$RC -Piper Sandler lowers Ready Capital target to #4.50 from $3.50 Neutral - $REXR -Evercore trims Rexford Industrial target to $40 from $41 In-Line - $RF -Truist raises Regions Financial target to $29 from $26 Hold - $RJF -Morgan Stanley raises Raymond James Financial target to $187 from $185 = Weight - https://twitter.com/i/web/status/2003266424765387164 https://twitter.com/i/web/status/2003266424765387164"
X Link 2025-12-23T00:48Z [----] followers, [---] engagements
"$OLMA $OPNT [--] people charged in $41M insider trading scheme tied to [--] biotechs https://www.fiercebiotech.com/biotech/6-people-charged-manipulating-stock-price-2-biotechs-41m-insider-trading-scheme https://www.fiercebiotech.com/biotech/6-people-charged-manipulating-stock-price-2-biotechs-41m-insider-trading-scheme"
X Link 2025-12-23T01:14Z [----] followers, [---] engagements
"$EVMN $KRYS $SPRY $TERN $XENE The top [--] stock picks for biotech in 2026: William Blair https://www.fiercebiotech.com/biotech/top-5-stock-picks-biotech-2026-william-blair https://www.fiercebiotech.com/biotech/top-5-stock-picks-biotech-2026-william-blair"
X Link 2025-12-23T15:14Z [----] followers, [---] engagements
"$HUT -Roth reiterates Hut [--] $60 target Buy - $INSP -UBS raises Inspire Medical Systems target to $91 from $89 Neutral - $INTA -Citi raises Intapp target to $49 from $46 Neutral - $JHG -Cowen lowers Janus Henderson target to $49 from $55 Downgrades to Hold from Buy -"
X Link 2025-12-23T22:59Z [----] followers, [---] engagements
"$SGHT -UBS raises Sight Sciences target to $12 from $7 Buy - $SLG -Goldman lowers S.L. Green Realty target to $42 from $48 Sell - $SPRB -Oppenheimer initiates Spruce Biosciences coverage at Outperform -Sets $283 target https://www.investing.com/news/analyst-ratings/oppenheimer-initiates-coverage-on-spruce-biosciences-stock-with-outperform-rating-93CH-4420915 https://www.investing.com/news/analyst-ratings/oppenheimer-initiates-coverage-on-spruce-biosciences-stock-with-outperform-rating-93CH-4420915"
X Link 2025-12-23T23:45Z [----] followers, [---] engagements
"$SVRA -Guggenheim reiterates Savara $11 target Buy -HC Wainwright raises target to $10 from $8 Buy - $SWK -Baird raises Stanley Black & Decker target to $85 from $75 Neutral - $TSLA -Canaccord raises Tesla target to $551 from $482 Buy -UBS maintains $247 target Sell -"
X Link 2025-12-23T23:48Z [----] followers, [---] engagements
"$WGO -Benchmark raises Winnebago target to $48 from $42 Buy - $WLK -UBS trims Westlake target to $92 from $93 Overweight - $WSM -Evercore raises Williams Sonoma target to $195 from $190 In-Line --"
X Link 2025-12-23T23:56Z [----] followers, [---] engagements
"$DOMO -Cantor Fitzgerald reiterates Domo $22 target Overweight - $DTE -BMO lowers DTE Energy target to $148 from $151 Market Perform - $EOLS -Needham maintains Evolus Hold rating - $EPM -Freedom Capital initiates Evolution Petroleum with a Buy rating $5.30 target -"
X Link 2025-12-24T18:03Z [----] followers, [---] engagements
"$CELH $GURU $MNST $PEP $STBFY Best Energy Drink Stocks WarrenAI Says to Buy for 2026: From Monster to Celsius https://www.investing.com/news/stock-market-news/best-energy-drink-stocks-warrenai-says-to-buy-for-2026-from-monster-to-celsius-93CH-4422709 https://www.investing.com/news/stock-market-news/best-energy-drink-stocks-warrenai-says-to-buy-for-2026-from-monster-to-celsius-93CH-4422709"
X Link 2025-12-24T23:23Z [----] followers, [---] engagements
"$DNTH $ORIC $SLDB $TNGX $TSHA $TYRA Biotech Stocks: Jefferies Names Its Top [--] Picks for [----] https://www.investing.com/news/stock-market-news/biotech-stocks-jefferies-names-its-6-top-picks-for-2026-93CH-4422319 https://www.investing.com/news/stock-market-news/biotech-stocks-jefferies-names-its-6-top-picks-for-2026-93CH-4422319"
X Link 2025-12-25T00:10Z [----] followers, [---] engagements
"- $AGIO -HC Wainwright raises Agios Pharmaceuticals target to $62 from $48 Buy -Truist lifts target to $38 from $32 Buy - $CHDN -Jefferies raises Churchill Downs target to $145 from $125 Buy - $LVS -Jefferies raises Las Vegas Sands target to $78 from $65 Buy -"
X Link 2025-12-25T19:22Z [----] followers, [---] engagements
"$AUTL -Needham raises Autolus Therapeutics target to $11 from $10 Buy - $BA -Tigress Financial initiates Boeing coverage with a Buy rating $275 target - $BLFS -HC Wainwright maintains BioLife Solutions $32 target Buy - $BNL -Morgan Stanley raises Broadstone Net Lease target to $19 from $18 = Weight - https://twitter.com/i/web/status/2005730326228918759 https://twitter.com/i/web/status/2005730326228918759"
X Link 2025-12-29T19:59Z [----] followers, [---] engagements
"$MTN -Truist lowers Vail Resorts target to $234 from $237 Buy - $NEM -Raymond James raises Newmont target to $111 from $99 Outperform - $NEXN -Rosenblatt maintains Nextel $15 target Buy -"
X Link 2025-12-29T20:28Z [----] followers, [---] engagements
"$BMR Beamr Completes SOC [--] Audit Reinforcing Enterprise-Grade Security and Privacy Operations https://www.stocktitan.net/news/BMR/beamr-completes-soc-2-audit-reinforcing-enterprise-grade-security-zye1sha8cqjq.html https://www.stocktitan.net/news/BMR/beamr-completes-soc-2-audit-reinforcing-enterprise-grade-security-zye1sha8cqjq.html"
X Link 2025-12-30T15:14Z [----] followers, [---] engagements
"$CALM -Stephens lowers Cal-Maine Foods target to $95 from $105 = Weight - $CARG -BTIG raises CarGurus target to $44 from $39 Buy - $CLPR -Raymond Janes reiterates Clipper Realty Underperform rating -"
X Link 2025-12-30T23:48Z [----] followers, [---] engagements
"$CLYM -Freedom Capital Markets initiates Climb Bio coverage with a Buy rating -Sets $9 target https://ng.investing.com/news/analyst-ratings/freedom-capital-markets-initiates-buy-rating-on-climb-bio-stock-with-9-target-93CH-2270167 https://ng.investing.com/news/analyst-ratings/freedom-capital-markets-initiates-buy-rating-on-climb-bio-stock-with-9-target-93CH-2270167"
X Link 2025-12-30T23:50Z [----] followers, [---] engagements
"$CVLT -Stephens initiates CommVault coverage with an Overweight rating $162 target - $DECK -UBS maintains Deckers Outdoor $157 target Buy - $DNLI -Jefferies maintains Denali Therapeutics $40 target Buy - $DRUG -HC Wainwright reiterates Bright Minds Biosciences $115 target Buy -"
X Link 2025-12-30T23:57Z [----] followers, [---] engagements
"$RPT -Wedbush initiates RPT Realty coverage at Outperform $4 target - $SHAK -Raymond James removes Shake Shack from Analyst Current Favorite List amid softer trends https://www.investing.com/news/analyst-ratings/shake-shack-stock-removed-from-raymond-james-favorite-list-amid-softer-trends-93CH-4425230 https://www.investing.com/news/analyst-ratings/shake-shack-stock-removed-from-raymond-james-favorite-list-amid-softer-trends-93CH-4425230"
X Link 2025-12-31T00:40Z [----] followers, [---] engagements
"$TWLO -Citizens JMP raises Twilio target to $185 from $165 Market Outperform - $UNCY -Guggenheim reiterates Unicycive Buy rating amid NDA resubmission -Maintains $46 target https://www.investing.com/news/analyst-ratings/guggenheim-reiterates-buy-rating-on-unicycive-stock-amid-nda-resubmission-93CH-4425234 https://www.investing.com/news/analyst-ratings/guggenheim-reiterates-buy-rating-on-unicycive-stock-amid-nda-resubmission-93CH-4425234"
X Link 2025-12-31T00:51Z [----] followers, [---] engagements
"$VIPS -Jefferies maintains Vipshop $22.60 target Buy - $VIR -HC Wainwright reiterates Vir Biotechnology $15 target Buy - $VRNS -Stephens initiates Varonis Systems coverage at = Weight $40 target - $WBS -Citi raises Webster Financial target to $77 from $68 Buy -"
X Link 2025-12-31T00:55Z [----] followers, [---] engagements
"$WTFC -Citi raises Wintrust Financial target to $167 from $159 Buy - $ZVRA -HC Wainwright maintains Zevra Therapeutics Buy rating on expanded access deal -Maintains $26 target -- https://www.investing.com/news/analyst-ratings/zevra-therapeutics-stock-maintains-buy-rating-at-hc-wainwright-on-expanded-access-deal-93CH-4425240 https://www.investing.com/news/analyst-ratings/zevra-therapeutics-stock-maintains-buy-rating-at-hc-wainwright-on-expanded-access-deal-93CH-4425240"
X Link 2025-12-31T00:57Z [----] followers, [---] engagements
"$BCAB BioAtla and GATC Health Announce a $40 Million Special Purpose Vehicle (SPV) Transaction to Advance Ozuriftamab Vedotin (Oz-V) into a Registrational Trial for 2L+ Oropharyngeal Squamous Cell Carcinoma (OPSCC) https://www.stocktitan.net/news/BCAB/bio-atla-and-gatc-health-announce-a-40-million-special-purpose-472ucpk84d4c.html https://www.stocktitan.net/news/BCAB/bio-atla-and-gatc-health-announce-a-40-million-special-purpose-472ucpk84d4c.html"
X Link 2025-12-31T15:04Z [----] followers, [---] engagements
"$BRZE -Needham reiterates Buy on Braze stock names it top pick for [----] -Maintains $50 target https://www.investing.com/news/analyst-ratings/needham-reiterates-buy-on-braze-stock-names-it-top-pick-for-2026-93CH-4426545 https://www.investing.com/news/analyst-ratings/needham-reiterates-buy-on-braze-stock-names-it-top-pick-for-2026-93CH-4426545"
X Link 2025-12-31T17:57Z [----] followers, [---] engagements
"$CZR Caesars Stock Down 30% This Past Year but One Fund Is Wagering $29 Million on a Turnaround https://www.fool.com/coverage/filings/2026/01/01/caesars-stock-down-30-this-past-year-but-one-fund-is-wagering-usd29-million-on-a-turnaround/ https://www.fool.com/coverage/filings/2026/01/01/caesars-stock-down-30-this-past-year-but-one-fund-is-wagering-usd29-million-on-a-turnaround/"
X Link 2026-01-01T22:52Z [----] followers, [---] engagements
"$PRAX Praxis Precision Medicines Stock Rises as FDA Grants Breakthrough Designation https://www.investing.com/news/analyst-ratings/praxis-precision-medicines-stock-rises-as-fda-grants-breakthrough-designation-93CH-4427871 https://www.investing.com/news/analyst-ratings/praxis-precision-medicines-stock-rises-as-fda-grants-breakthrough-designation-93CH-4427871"
X Link 2026-01-02T18:09Z [----] followers, [---] engagements
"$AMSC $MGY $PBW $XOP Clear Street Names American Superconductor and Magnolia Oil & Gas as Top [----] Picks https://www.investing.com/news/analyst-ratings/clear-street-names-american-superconductor-magnolia-oil--gas-as-top-2026-picks-93CH-4427616 https://www.investing.com/news/analyst-ratings/clear-street-names-american-superconductor-magnolia-oil--gas-as-top-2026-picks-93CH-4427616"
X Link 2026-01-02T18:35Z [----] followers, [---] engagements
"$ASO -Jefferies lifts Academy Sports target to $65 from $64 Buy - $ASTL -Jefferies initiates Algoma Steel coverage at Hold C$6 target - $ATAT -CLSA initiates Atour Lifestyle coverage at Outperform citing company's unique design and service $49 target https://www.investing.com/news/analyst-ratings/clsa-initiates-atour-lifestyle-stock-with-outperform-rating-49-target-93CH-4427511 https://www.investing.com/news/analyst-ratings/clsa-initiates-atour-lifestyle-stock-with-outperform-rating-49-target-93CH-4427511"
X Link 2026-01-02T18:44Z [----] followers, [---] engagements
"$HOLO MicroCloud Hologram Inc. Launches Q-DPC Accelerator: Quantum-Empowered Density Peak Clustering's Strategy Evaluation Performance Leap Solution https://www.stocktitan.net/news/HOLO/micro-cloud-hologram-inc-launches-q-dpc-accelerator-quantum-hg25uxvdd9kl.html https://www.stocktitan.net/news/HOLO/micro-cloud-hologram-inc-launches-q-dpc-accelerator-quantum-hg25uxvdd9kl.html"
X Link 2026-01-02T21:09Z [----] followers, [---] engagements
"$AIRO -Mizuho lowers AIRO target to $20 from $25 Outperform - $AKAM -RBC raises Akamai target to $90 from $80 Sector Perform -Piper Sandler lifts target to $89 from $86 Neutral - $AKTX -Ladenburg Thalman initiates Akari Therapeutics coverage with a Buy rating $1 target -"
X Link 2026-01-05T17:33Z [----] followers, [---] engagements
"$AVGO -Goldman adds Broadcom to US Conviction Buy List Maintains Buy rating $450 target - $AVTR -Evercore lowers Avantor target to $12 from $14 Downgrades to In-Line from Outperform - $AXSM -Needham raises Axsome Therapeutics target to $225 from $169 Buy -HC Wainwright lifts target to $200 from $185 Buy - https://twitter.com/i/web/status/2008245005044117985 https://twitter.com/i/web/status/2008245005044117985"
X Link 2026-01-05T18:31Z [----] followers, [---] engagements
"$BBNX -Bank of America raises Beta Bionics target to $33 from $30 Buy - $BBSI -Barrington Research maintains Barrett Business Services $46 target Outperform - $BDX -Bank of America raises Becton Dickinson target to $207 from $190 Neutral -"
X Link 2026-01-05T18:37Z [----] followers, [---] engagements
"$BLFS -Northland raises BioLife Solutions target to $34 from $31 Outperform - $BNL -Cantor Fitzgerald trims Broadstone Net Lease target to $20 from $21 Overweight - $BRKR -Guggenheim raises Bruker target to $53 from $45 Buy - $BROS -Cowen raises Dutch Bros target to $73 from $70 Buy - https://twitter.com/i/web/status/2008255215682846985 https://twitter.com/i/web/status/2008255215682846985"
X Link 2026-01-05T19:12Z [----] followers, [---] engagements
"$BRSP -B. Riley resumes BrightSpire Financial coverage with a Buy rating $7.50 target - $BSY -RBC lowers Bentley Systems target to $48 from $65 Outperform - $C -Wells Fargo raises Citigroup target to $150 from $125 Overweight -Barclays lifts target to $146 from $115 Overweight -"
X Link 2026-01-05T19:14Z [----] followers, [---] engagements
"$CHD -Raymond James upgrades Church & Dwight to Outperform from Market Perform $100 target -Wells Fargo lowers target to $92 from $100 Overweight - $CHDN -Wells Fargo raisesChurchill Downs target to $125 from $115 Overweight -"
X Link 2026-01-05T19:23Z [----] followers, [---] engagements
"$EPC -Wells Fargo lowers Edgewell Personal Care target to $20 from $23 Overweight - $EPD -Raymond James downgrades Enterprise Product Partners to Outperform from Strong Buy $36 target - $EQH -JPMorgan upgrades Equitable to Overweight from Neutral Lowers target to $60 from $64 -"
X Link 2026-01-06T00:26Z [----] followers, [---] engagements
"$EQT -Bernstein lifts EQT target to $73 from $72 Outperform - $ESTC -RBC lowers Elastic target to $95 from $115 Outperform -Jefferies cuts target to $95 from $105 Buy - $ETOR -Goldman lowers eToro target to $39 from $48 Downgrades to Neutral from Buy -"
X Link 2026-01-06T00:28Z [----] followers, [---] engagements
"$FWRD -Susquehanna raises Forward Air target to $45 from $42 Positive - $GDDY -Jefferies lowers GoDaddy target to $149 from $150 Hold - $GEHC -Evercore raises GE Healthcare target to $95 from $92 Outperform -Bank of America lifts target to $92 from $82 Neutral -"
X Link 2026-01-06T01:01Z [----] followers, [---] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing